Objective Salmonella species (also called serovars) are important zoonotic pathogens that cause gastrointestinal disease in humans and animals. Poultry products contaminated with these pathogens are one of the major sources of human Salmonella infections worldwide. Salmonella Enteritidis and Typhimurium are the serovars most frequently associated with human food poisoning (78.3 % of all cases in 2003). The serovars of Salmonella having places three to five are Virchow, Infantis and Hadar. Vaccination of chickens, along with other intervention measures in the overall biosecurity system of chicken farms, is an important strategy that is currently being used to reduce the levels of Salmonella in poultry flocks, which will ultimately lead to lower rates of human infections. However, despite numerous studies that have been performed, there is still a need for safer, well-defined Salmonella vaccines. At Immunolab we invented SAL ETHVI – innovative vaccine against above listed 5 serovars of Salmonella. We also breakthrough the technology for the vaccine production in a way that allows any configuration of serotypes, therefore if there is a need for a vaccine against another serovar, its production will be very easy. The end users of the vaccine will be poultry breeders, namely hens and broilers flocks owners. The unique features of our vaccine constituting our competitive adventage comprise : (1) easy application ; (2) low price ; (3) immediate vaccination upon hatching; (4) no risk of bacteria activation and spreading. We have filled a patent application for the technology and upon the vaccine registration and certification, we aim to commercialize it at the broilers markets of the biggest European poultry meat producers: Poland, Germany, France, the Netherlands, United Kingdom and Russia. We are applying for the SME Instrument Phase 1, aiming to complete the feasibility study and a business plan including industry value-chain mapping, market sizing and critical risks assessment. Fields of science natural sciencesbiological sciencesmicrobiologybacteriologymedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccinesengineering and technologyother engineering and technologiesfood technologyfood safetymedical and health scienceshealth sciencespublic healthepidemiologyzoonosismedical and health sciencesclinical medicinegastroenterology Programme(s) H2020-EU.3.2. - SOCIETAL CHALLENGES - Food security, sustainable agriculture and forestry, marine, maritime and inland water research, and the bioeconomy Main Programme H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument Topic(s) SFS-08-2015-1 - Resource-efficient eco-innovative food production and processing Call for proposal H2020-SMEInst-2014-2015 See other projects for this call Sub call H2020-SMEINST-1-2015 Funding Scheme SME-1 - SME instrument phase 1 Coordinator ZAKLAD BADAWCZO-WDROZENIOWY OSRODKASALMONELLA IMMUNOLAB SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA Net EU contribution € 50 000,00 Address Ul. kladki 24 80-180 Gdansk Poland See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Makroregion północny Pomorskie Starogardzki Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 21 429,00 Participants (1) Sort alphabetically Sort by Net EU contribution Expand all Collapse all NatVet sp. z o. o. Poland Net EU contribution € 0,00 Address Trzy lipy 3 80-172 Gdansk See on map SME The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed. Yes Region Makroregion północny Pomorskie Trójmiejski Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 0,00
